Copied
 
 
2023, DKK
16.05.2024
Bruttoresultat

4.542'

Primær drift

-5.878'

Årets resultat

-4.526'

Aktiver

52.172'

Kortfristede aktiver

38.404'

Egenkapital

50.682'

Afkastningsgrad

-11 %

Soliditetsgrad

97 %

Likviditetsgrad

+500%

Resultat
16.05.2024
Årsrapport
2023
16.05.2024
2021
16.03.2023
Nettoomsætning
Bruttoresultat4.541.5803.423.504
Resultat af primær drift-5.878.346-2.880.170
Indtægter af kapitalandele (tilknyttede og associerede) 00
Finansielle indtægter298.9520
Finansieringsomkostninger-347.749-210.063
Andre finansielle omkostninger00
Resultat før skat-5.927.143-3.090.233
Resultat-4.526.454-2.161.140
Forslag til udbytte00
Aktiver
16.05.2024
Årsrapport
2023
16.05.2024
2021
16.03.2023
Kortfristede varebeholdninger00
Kortfristede tilgodehavender fra salg og tjenesteydelser 3.557.7792.507.217
Likvider34.845.8362.796.877
Kortfristede aktiver38.403.6155.304.094
Immaterielle aktiver og goodwill9.661.3153.923.794
Finansielle anlægsaktiver517.512350.700
Materielle aktiver3.589.9903.509.560
Langfristede aktiver13.768.8177.784.054
Aktiver52.172.43213.088.148
Aktiver
16.05.2024
Passiver
16.05.2024
Årsrapport
2023
16.05.2024
2021
16.03.2023
Forslag til udbytte00
Egenkapital50.682.2017.877.435
Hensatte forpligtelser00
Langfristet gæld til banker00
Anden langfristet gæld0
Leverandører af varer og tjenesteydelser764.749527.910
Kortfristede forpligtelser1.490.2311.050.713
Gældsforpligtelser1.490.2315.210.713
Forpligtelser1.490.2315.210.713
Passiver52.172.43213.088.148
Passiver
16.05.2024
Nøgletal
16.05.2024
Årsrapport
2023
16.05.2024
2021
16.03.2023
Afkastningsgrad -11,3 %-22,0 %
Dækningsgrad Na.Na.
Resultatgrad Na.Na.
Varelagerets omsætningshastighed Na.Na.
Egenkapitals-forretning -8,9 %-27,4 %
Payout-ratio Na.Na.
Gældsdæknings-nøgletal -1.690,4 %-1.371,1 %
Soliditestgrad 97,1 %60,2 %
Likviditetsgrad 2.577,0 %504,8 %
Resultat
16.05.2024
Gæld
16.05.2024
Årsrapport
16.05.2024
Nyeste:01.01.2023- 31.12.2023(offentliggjort: 16.05.2024)
Information om virksomhedens regnskabsklasse:The annual report of Bioomix A/S for 2023 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B, as well as provisions applying to reporting class C entities. The accounting policies applied are consistent with those of last year. The annual report for 2023 is presented in DKK. Comparative figures include 17 months, as 2021/22 was the company's first financial year
Beretning
16.05.2024
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:The supervisory board and executive board have today discussed and approved the annual report of Bioomix A/S for the financial year 1 January - 31 December 2023.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Business review Bioomix is a Danish company that develops, produces, and sells microbiological products. Our vision is to make agriculture more sustainable, profitable, and productive by creating effective and natural microbiological alternatives to harmful and costly agrochemicals. The past year, 2023, was a great year for our company and we passed several important milestones. Here are some of the highlights.